This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. MEMPHIS, Tenn. — In just the second week of ...
Abbott Laboratories ABT recently received FDA approval for its Eterna spinal cord stimulation (SCS) system for treating chronic pain. The Eterna SCS system is the smallest implantable, rechargeable ...
SAN DIEGO — The next advance in spinal cord stimulation (SCS) could be a closed-loop system that uses evoked compound action potentials (ECAPs) to maintain therapeutic activation, results of the phase ...
It was originally approved in 2019 for the treatment of chronic pain. The Food and Drug Administration (FDA) has approved the Proclaim™ XR spinal cord stimulation (SCS) system for the treatment of ...
DUBLIN, Dec. 9, 2019 /PRNewswire/ -- The "Global Spinal Cord Stimulation (SCS) Market: Size, Trends & Forecasts (2019-2023)" report has been added to ResearchAndMarkets.com's offering. Global Spinal ...
The Senza SCS System is a neuromodulation device designed to deliver electrical stimulation using implantable leads and a rechargeable, implantable pulse generator. The Food and Drug Administration ...
In particular, the non-rechargeable system improves patient convenience by removing the burden of regularly recharging the SCS system. The system’s upgradable platform allows patients to access future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback